Anlito, Sandro M.

HRN: 23-58-16  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/21/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/21/2023
08/28/2023
IVTT
75mg
OD
AGE; TC Sepsis
Waiting Final Action 
08/21/2023
CEFTRIAXONE 1G (VIAL)
08/21/2023
08/28/2023
IV DRIP
750
OD
AGE; TC Sepsis
Waiting Final Action 
08/29/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/29/2023
09/05/2023
IV
750mg
TID
AGE W/ MOD. DHN
Waiting Final Action 
08/30/2023
MUPIROCIN 2%, 15G (TUBE)
08/30/2023
09/06/2023
TOPICAL
15g
BID
Rashes
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: